Viewing Study NCT05491057


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2025-12-25 @ 4:08 PM
Study NCT ID: NCT05491057
Status: NOT_YET_RECRUITING
Last Update Posted: 2022-08-08
First Post: 2022-07-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Treatment Patterns of Neratinib in HER2+ EBC in China
Sponsor: Pierre Fabre Medicament
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module